enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Vildagliptin/metformin - Wikipedia

    en.wikipedia.org/wiki/Vildagliptin/metformin

    It was approved for use in the European Union in November 2007, [4] and the approval was updated in 2008. [ 5 ] [ 6 ] [ 7 ] It combines 50 mg vildagliptin with either 500, 850, or 1000 mg metformin .

  3. Metformin - Wikipedia

    en.wikipedia.org/wiki/Metformin

    Formulations are 500/1, 500/2, 500/4, 1000/2, and 1000 mg/4 mg of metformin/rosiglitazone. In 2009, it was the most popular metformin combination. [178] In 2005, the stock of Avandamet was removed from the market, after inspections showed the factory where it was produced was violating good manufacturing practices. [179]

  4. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    SGLT2 inhibitors (also called gliflozins or flozins) are a class of medications that inhibit sodium-glucose transport proteins in the nephron (the functional units of the kidney), unlike SGLT1 inhibitors that perform a similar function in the intestinal mucosa. The foremost metabolic effect of this is to inhibit reabsorption of glucose in the ...

  5. Can Metformin Cause Hair Loss? - AOL

    www.aol.com/metformin-cause-hair-loss-115700854.html

    We have answers. Metformin isn’t known to cause hair loss. However, hair loss is correlated with type 2 diabetes. So, technically, you could take metformin for hair loss related to diabetes or ...

  6. Sitagliptin/metformin - Wikipedia

    en.wikipedia.org/wiki/Sitagliptin/metformin

    It contains sitagliptin (a dipeptidyl peptidase-4 inhibitor) and metformin (a biguanide). [5] The combination was approved for medical use in the United States in 2007. [5] In 2022, it was the 182nd most commonly prescribed medication in the United States, with more than 2 million prescriptions. [12] [13] It is available as a generic medication ...

  7. Empagliflozin/metformin - Wikipedia

    en.wikipedia.org/wiki/Empagliflozin/metformin

    Empagliflozin/metformin was approved for use in the European Union in May 2015. [5] Empagliflozin/metformin was approved for use in the United States in August 2015. [6] [11] The extended release version was approved for use in the United States in December 2016. [12] [13] Empagliflozin/metformin was approved for use in Australia in May 2020. [2]

  8. Should You Skip Your Weight-Loss Injectable to Enjoy Holiday ...

    www.aol.com/skip-weight-loss-injectable-enjoy...

    As GLP-1 weight-loss injectables grow in popularity, some people are wondering if they can skip the drugs — which impact satiety — to indulge in holiday meals. The medication is not a “magic ...

  9. Canagliflozin/metformin - Wikipedia

    en.wikipedia.org/wiki/Canagliflozin/metformin

    [1] [2] [3] It is used in combination with diet and exercise. [1] [2] [3] It is taken by mouth. [1] [2] [3] The most common side effects include hypoglycemia (low blood glucose levels) when used in combination with insulin or a sulphonylurea and vulvovaginal candidiasis (thrush, a fungal infection of the female genital area caused by Candida). [3]